APOBEC3B inhibitors (ApoGen Biotechnologies)

N/A

Report date: 2025/03/14 18:14:23
NME

Base Information

Drug NameAPOBEC3B inhibitors (ApoGen Biotechnologies)
Drug Alias NameAPOBEC3B inhibitors (University of Minnesota)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAPOBEC3G deaminase inhibitors
TargetsAPOBEC3G deaminase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Minnesota
China Registration ClassN/A

Develop Information

Active CompaniesApoGen Biotechnologies Inc
Inactive CompaniesUniversity Of Minnesota
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A